Cargando…

Myeloproliferative neoplasms

Detalles Bibliográficos
Autor principal:	Cross, Nick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2019
Materias:	Myeloproliferative Neoplasms
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8925673/ https://www.ncbi.nlm.nih.gov/pubmed/35309822 http://dx.doi.org/10.1097/HS9.0000000000000263

Ejemplares similares

Genetic basis and molecular profiling in myeloproliferative neoplasms
por: Luque Paz, Damien, et al.
Publicado: (2023)

Relationship between disease biology and clinical phenotype in myeloproliferative neoplasms
por: Nangalia, Jyoti
Publicado: (2019)

MPN-433: Outcomes of COVID-19 in Hematopoietic Stem Cell Transplant Recipients: A Single-Institution, Observational Study
por: Dwabe, Sami, et al.
Publicado: (2021)

Philadelphia-Negative Myeloproliferative Neoplasms Around the COVID-19 Pandemic
por: Barbui, Tiziano, et al.
Publicado: (2021)

Towards a Personalized Definition of Prognosis in Philadelphia-Negative Myeloproliferative Neoplasms
por: Mora, Barbara, et al.
Publicado: (2022)

Biology and therapeutic targeting of molecular mechanisms in MPNs
por: How, Joan, et al.
Publicado: (2023)

JAK2(V617F) allele burden in polycythemia vera: burden of proof
por: Moliterno, Alison R., et al.
Publicado: (2023)

Myelofibrosis
por: Passamonti, Francesco, et al.
Publicado: (2023)

Age‐related macular degeneration and myeloproliferative neoplasms – A common pathway
por: Liisborg, Charlotte
Publicado: (2022)

MF management
por: Bose, Prithviraj, et al.
Publicado: (2019)

Fibrosis driving myofibroblast precursors in MPN and new therapeutic pathways
por: Gleitz, Hélène F.E., et al.
Publicado: (2019)

Haploidentical donor hematopoietic cell transplantation for myelodysplastic/myeloproliferative overlap neoplasms: results from a North American collaboration
por: Jain, Tania, et al.
Publicado: (2023)

ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms
por: Shi, Zhongxun, et al.
Publicado: (2022)

Antibody and T-Cell Responses to COVID-19 Vaccination in Myeloproliferative Neoplasm Patients
por: How, Joan, et al.
Publicado: (2021)

The Use of Anagrelide in Myeloproliferative Neoplasms, with Focus on Essential Thrombocythemia
por: Birgegård, Gunnar
Publicado: (2016)

Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care
por: Langlais, Blake T., et al.
Publicado: (2020)

Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19
por: Leiva, Orly, et al.
Publicado: (2021)

Ruxolitinib: Long-Term Management of Patients with Myelofibrosis and Future Directions in the Treatment of Myeloproliferative Neoplasms
por: Yacoub, A., et al.
Publicado: (2014)

Biliary tract neoplasms: diagnosis and staging
por: Gore, Richard M., et al.
Publicado: (2007)

Autoantibodies Against Type I IFNs in Patients with Ph-Negative Myeloproliferative Neoplasms
por: Borsani, Oscar, et al.
Publicado: (2021)

Cancer, an introduction /
por: Creasey, William A.
Publicado: (1981)

Posterior Reversible Encephalopathy Syndrome in ALL
por: Millichap, J. Gordon
Publicado: (2015)

Retrospective analysis of pacritinib in patients with myelofibrosis and severe thrombocytopenia
por: Verstovsek, Srdan, et al.
Publicado: (2021)

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis
por: Mei, Matthew, et al.
Publicado: (2022)

Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis
por: Murthy, Guru Subramanian Guru, et al.
Publicado: (2023)

Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial
por: Verstovsek, Srdan, et al.
Publicado: (2023)

Preliminary experience with a new institutional tumor board dedicated to patients with neuroendocrine neoplasms
por: Trikalinos, Nikolaos A., et al.
Publicado: (2022)

Spatial and temporal heterogeneity of digestive neuroendocrine neoplasms
por: Bourdeleau, Pauline, et al.
Publicado: (2023)

Myeloproliferative neoplasms
por: Kiladjian, Jean-Jacques
Publicado: (2018)

New Directions in Imaging Neuroendocrine Neoplasms
por: Refardt, Julie, et al.
Publicado: (2021)

New Developments in Gastric Neuroendocrine Neoplasms
por: Exarchou, Klaire, et al.
Publicado: (2022)

Epigenetics in Myeloproliferative Neoplasms
por: McPherson, Suzanne, et al.
Publicado: (2017)

Aetiology of Myeloproliferative Neoplasms
por: McMullin, Mary Frances, et al.
Publicado: (2020)

The microenvironment in myeloproliferative neoplasm
por: Méndez-Ferrer, Simón, et al.
Publicado: (2018)

Spleen in myeloproliferative neoplasms
por: Barosi, Giovanni
Publicado: (2018)

Epigenetics in myeloproliferative neoplasms
por: Greenfield, Graeme, et al.
Publicado: (2023)

Update on Histological Reporting Changes in Neuroendocrine Neoplasms
por: Bräutigam, Konstantin, et al.
Publicado: (2021)

The Role of Patient Support Groups in Neuroendocrine Neoplasms
por: Kolarova, Teodora, et al.
Publicado: (2021)

Imaging in cervical nodal metastases of unknown primary
por: Hermans, Robert
Publicado: (2011)

Pancreatic adenocarcinoma: diagnosis and staging using multidetector-row computed tomography (MDCT) and magnetic resonance imaging (MRI)
por: Francis, Isaac R.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_vqf1psscjiu5clfj24pl1vqo5g